Literature DB >> 1381414

Smooth muscle can comprise the sarcomatous component of gliosarcomas.

S F Haddad1, S A Moore, R L Schelper, J A Goeken.   

Abstract

The sarcomatous component of gliosarcomas is thought by many to originate from the vascular proliferation seen in glioblastoma multiforme and has, therefore, been assumed to be endothelial. Immunohistochemical staining of four gliosarcomas has led us to an alternate theory. Pathologically all four tumors were composed of at least two cell types; the first had a stellate, glial appearance and the second was either spindled or polygonal in shape. Polygonal cells were associated with glomeruloid vascular structures in some areas. Both components of each neoplasm were cytologically malignant. Glial fibrillary acidic protein and S-100 antibodies stained most of the glial-appearing cells and some of the spindled cells, but not the polygonal cells. Muscle specific alpha-actin and smooth muscle specific alpha-actin antibodies stained only the malignant spindled and polygonal cells and normal vascular smooth muscle. Ulex europaeus agglutinin I and anti-factor VIII/related antigen antibody stained only cells lining vascular lumina. The staining results suggest that the malignant mesenchymal component of these tumors is of smooth muscle origin. Having demonstrated elsewhere that glomeruloid vascular structures of glioblastoma multiforme contain smooth muscle cells, we propose here that gliosarcomas can represent one end of the spectrum of glioma-induced vascular smooth muscle proliferation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1381414     DOI: 10.1097/00005072-199209000-00003

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  21 in total

1.  Gliosarcoma: A rare primary CNS tumor. Presentation of two cases.

Authors:  José Pardo; Mauricio Murcia; Felip García; Arnaldo Alvarado
Journal:  Rep Pract Oncol Radiother       Date:  2010-07-07

Review 2.  Angiogenesis in brain tumors; pathobiological and clinical aspects.

Authors:  P Wesseling; D J Ruiter; P C Burger
Journal:  J Neurooncol       Date:  1997-05       Impact factor: 4.130

3.  Epithelial and pseudoepithelial differentiation in glioblastoma and gliosarcoma: a comparative morphologic and molecular genetic study.

Authors:  Fausto J Rodriguez; Bernd W Scheithauer; Caterina Giannini; Sandra C Bryant; Robert B Jenkins
Journal:  Cancer       Date:  2008-11-15       Impact factor: 6.860

4.  Adipose tissue and smooth muscle in a primitive neuroectodermal tumor of cerebrum.

Authors:  L Selassie; R Rigotti; J J Kepes; J Towfighi
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

5.  Intradural primary chondroblastic osteosarcoma: case report.

Authors:  M T Walker; L R Toye; S W Coons; R W Porter; R C Wallace
Journal:  AJNR Am J Neuroradiol       Date:  2001 Nov-Dec       Impact factor: 3.825

6.  Vascularization pattern of C6 glioma is modified with medroxyprogesterone acetate and ibuprofen in Wistar rat brain.

Authors:  M A Altinoz; E Ozar; M Taskin; E Bozcali; A Bilir; T Altug; A Aydiner; A Sav
Journal:  Pathol Oncol Res       Date:  2001       Impact factor: 3.201

7.  Cellular components of microvascular proliferation in human glial and metastatic brain neoplasms. A light microscopic and immunohistochemical study of formalin-fixed, routinely processed material.

Authors:  P Wesseling; J J Vandersteenhoven; B T Downey; D J Ruiter; P C Burger
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

8.  Gliosarcomas: analysis of 11 cases do two subtypes exist?

Authors:  Maurizio Salvati; Emanuela Caroli; Antonino Raco; Felice Giangaspero; Roberto Delfini; Luigi Ferrante
Journal:  J Neurooncol       Date:  2005-08       Impact factor: 4.130

9.  Gliosarcoma stem cells undergo glial and mesenchymal differentiation in vivo.

Authors:  Ana C deCarvalho; Kevin Nelson; Nancy Lemke; Norman L Lehman; Ali S Arbab; Steven Kalkanis; Tom Mikkelsen
Journal:  Stem Cells       Date:  2010-02       Impact factor: 6.277

10.  High-grade glioma before and after treatment with radiation and Avastin: initial observations.

Authors:  Ingeborg Fischer; Clare H Cunliffe; Robert J Bollo; Shahzad Raza; David Monoky; Luis Chiriboga; Erik C Parker; John G Golfinos; Patrick J Kelly; Edmond A Knopp; Michael L Gruber; David Zagzag; Ashwatha Narayana
Journal:  Neuro Oncol       Date:  2008-08-12       Impact factor: 12.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.